FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1984385389> ?p ?o ?g. }

• W1984385389 endingPage "399" @default.
• W1984385389 startingPage "395" @default.
• W1984385389 abstract "Abstract Background : Celiac disease, also known as gluten‐sensitive enteropathy, is a chronic inflammation disease of the small intestinal mucosa. Detection of Ig‐A antigliadin antibodies (AGA) and antiendomysial antibodies (EMA) in serum is important in the diagnosis and screening for celiac disease. Antiendomysial antibodies have greater sensitivity compared to antigliadin antibodies. It has been reported that the prevalence of celiac disease is higher in children with Down syndrome than the other autoimmune conditions. The aim of the present study was to investigate the incidence of celiac disease in children with Down syndrome, to assess the availability of Ig‐A AGA and EMA for serologic screening, and to highlight the importance of follow‐up for children with Down syndrome. Methods : Forty‐seven children with Down syndrome without known celiac disease were tested for total blood count, thyroid function tests, immunoglobulin values, Ig‐A AGA and EMA. Duodenal biopsy was performed on eight patients who showed at least one serologically positive marker. Results : The ages of the children with Down syndrome ranged from 2 to 18 years (30 boys/17 girls). The mean age was 6.55 ± 3.88. Total blood count and immunoglobulin values were normal. Eleven of the 47 patients (23.40%) were found to be serologically positive, 10 (21.28%) having antigliadin antibody concentrations above normal; and six (12.77%) being positive for antiendomysial antibody. In five patients (10.64%), both Ig‐A AGA and EMA concentrations were high and positive. Duodenal biopsies of three of eight cases (37.50%) revealed villous atrophy, lymphocyte infiltration and crypt hyperplasia. Three cases with abnormal biopsy results (100%) were below the 10th percentile for weight and height. Hypo­thyroidism was detected in one of 11 cases where at least one serologic marker was positive. Conclusion : Children with Down syndrome should be carefully examined in their follow up, and celiac disease should be considered in cases with growth retardation. Ig‐A antigliadin antibodies and EMA are non‐invasive, cheap and readily available serologic screening tests for celiac disease, and the positivity of both markers gives the most reliable result." @default.
• W1984385389 created "2016-06-24" @default.
• W1984385389 creator A5006715575 @default.
• W1984385389 creator A5037180436 @default.
• W1984385389 creator A5053124932 @default.
• W1984385389 creator A5055888190 @default.
• W1984385389 creator A5062702338 @default.
• W1984385389 creator A5074441182 @default.
• W1984385389 creator A5075304290 @default.
• W1984385389 creator A5089428151 @default.
• W1984385389 date "2003-08-01" @default.
• W1984385389 modified "2023-10-15" @default.
• W1984385389 title "Celiac disease in children with Down syndrome: Importance of follow-up and serologic screening" @default.
• W1984385389 cites W1968847761 @default.
• W1984385389 cites W1970822344 @default.
• W1984385389 cites W1976650628 @default.
• W1984385389 cites W1985138999 @default.
• W1984385389 cites W2005405910 @default.
• W1984385389 cites W2010756121 @default.
• W1984385389 cites W2017773130 @default.
• W1984385389 cites W2020247070 @default.
• W1984385389 cites W2025276762 @default.
• W1984385389 cites W2026407198 @default.
• W1984385389 cites W2026802333 @default.
• W1984385389 cites W2058702995 @default.
• W1984385389 cites W2075656259 @default.
• W1984385389 cites W2088638679 @default.
• W1984385389 cites W2128153629 @default.
• W1984385389 cites W2150376007 @default.
• W1984385389 cites W2154615444 @default.
• W1984385389 cites W2161211626 @default.
• W1984385389 cites W2163023572 @default.
• W1984385389 cites W2168041308 @default.
• W1984385389 cites W2326235460 @default.
• W1984385389 cites W4250411457 @default.
• W1984385389 doi "https://doi.org/10.1046/j.1442-200x.2003.01755.x" @default.
• W1984385389 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/12911473" @default.
• W1984385389 hasPublicationYear "2003" @default.
• W1984385389 type Work @default.
• W1984385389 sameAs 1984385389 @default.
• W1984385389 citedByCount "21" @default.
• W1984385389 countsByYear W19843853892012 @default.
• W1984385389 countsByYear W19843853892013 @default.
• W1984385389 countsByYear W19843853892014 @default.
• W1984385389 countsByYear W19843853892015 @default.
• W1984385389 countsByYear W19843853892017 @default.
• W1984385389 countsByYear W19843853892019 @default.
• W1984385389 countsByYear W19843853892020 @default.
• W1984385389 crossrefType "journal-article" @default.
• W1984385389 hasAuthorship W1984385389A5006715575 @default.
• W1984385389 hasAuthorship W1984385389A5037180436 @default.
• W1984385389 hasAuthorship W1984385389A5053124932 @default.
• W1984385389 hasAuthorship W1984385389A5055888190 @default.
• W1984385389 hasAuthorship W1984385389A5062702338 @default.
• W1984385389 hasAuthorship W1984385389A5074441182 @default.
• W1984385389 hasAuthorship W1984385389A5075304290 @default.
• W1984385389 hasAuthorship W1984385389A5089428151 @default.
• W1984385389 hasConcept C118552586 @default.
• W1984385389 hasConcept C120665830 @default.
• W1984385389 hasConcept C121332964 @default.
• W1984385389 hasConcept C126322002 @default.
• W1984385389 hasConcept C159654299 @default.
• W1984385389 hasConcept C203014093 @default.
• W1984385389 hasConcept C2778426112 @default.
• W1984385389 hasConcept C2779134260 @default.
• W1984385389 hasConcept C2779954681 @default.
• W1984385389 hasConcept C2780349322 @default.
• W1984385389 hasConcept C2993432164 @default.
• W1984385389 hasConcept C45189115 @default.
• W1984385389 hasConcept C61511704 @default.
• W1984385389 hasConcept C71924100 @default.
• W1984385389 hasConcept C90924648 @default.
• W1984385389 hasConceptScore W1984385389C118552586 @default.
• W1984385389 hasConceptScore W1984385389C120665830 @default.
• W1984385389 hasConceptScore W1984385389C121332964 @default.
• W1984385389 hasConceptScore W1984385389C126322002 @default.
• W1984385389 hasConceptScore W1984385389C159654299 @default.
• W1984385389 hasConceptScore W1984385389C203014093 @default.
• W1984385389 hasConceptScore W1984385389C2778426112 @default.
• W1984385389 hasConceptScore W1984385389C2779134260 @default.
• W1984385389 hasConceptScore W1984385389C2779954681 @default.
• W1984385389 hasConceptScore W1984385389C2780349322 @default.
• W1984385389 hasConceptScore W1984385389C2993432164 @default.
• W1984385389 hasConceptScore W1984385389C45189115 @default.
• W1984385389 hasConceptScore W1984385389C61511704 @default.
• W1984385389 hasConceptScore W1984385389C71924100 @default.
• W1984385389 hasConceptScore W1984385389C90924648 @default.
• W1984385389 hasIssue "4" @default.
• W1984385389 hasLocation W19843853891 @default.
• W1984385389 hasLocation W19843853892 @default.
• W1984385389 hasOpenAccess W1984385389 @default.
• W1984385389 hasPrimaryLocation W19843853891 @default.
• W1984385389 hasRelatedWork W1823518919 @default.
• W1984385389 hasRelatedWork W1964040859 @default.
• W1984385389 hasRelatedWork W1993330227 @default.
• W1984385389 hasRelatedWork W2037579679 @default.
• W1984385389 hasRelatedWork W2046167023 @default.
• W1984385389 hasRelatedWork W2060186160 @default.

• next